Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation
May 2, 2013

We work with researchers from big and large pharma to discover new CROs and outsource drug discovery. Whether they have worked with a handful of...

Apr 30, 2013

As previously discussed, drug development costs have been rising to almost prohibitive levels. In 1975, the average approved drug cost $100 million...

Apr 24, 2013

Outsourcing a project is often seen as an all or nothing proposition: either an entire project is outsourced or everything is kept in house. The...

Apr 23, 2013

This is Part 1 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...

Apr 18, 2013

You’ve made the decision to outsource to a contract research organization, but you’re not sure where to start. Do you send it overseas for lower...

Apr 18, 2013

We found this on twitter today. It appears @mrgunn doesn’t really grasp the bigger picture of what we do if he thinks of @scientist_com as “just...

Apr 16, 2013

In two compelling presentations at the Bio-IT World Conference last week, Atul Butte and Steven Salzberg provided formidable advocacy for the...

Apr 16, 2013

The health and behavior of each one of our cells is influenced by both genetics and epigenetics. Drug discovery has historically targeted proteins...

Apr 11, 2013

We’ve established that near sourcing has its advantages over outsourcing, but what are the best areas to near source? CROs, biotechs, and pharmas...

Apr 9, 2013

What is the most successful preclinical strategy for drug discovery? Finding the answer to this question is important if pharma is to keep its...